Peripheral neuropathy, a condition resulting from damage to the peripheral nerves, presents a diagnostic challenge due to its diverse etiologies and clinical manifestations. This article provides a comprehensive guide to the evaluation of this complex disorder.
Peripheral neuropathy can stem from a multitude of etiologies, including metabolic, toxic, and autoimmune conditions. Diabetes mellitus remains the most common cause. A thorough patient history and physical examination are paramount in identifying potential causes and directing further diagnostic evaluation.
Patients may present with sensory, motor, or autonomic symptoms, depending on the affected nerves. Sensory symptoms include numbness and tingling, while motor symptoms involve muscle weakness. Autonomic symptoms can affect various systems leading to symptoms like orthostatic hypotension or gastrointestinal disturbances.
After a comprehensive history and physical examination, laboratory tests should be guided by suspected etiologies. Nerve conduction studies and electromyography can help confirm the diagnosis and classify the neuropathy. In some cases, nerve biopsy may be required.
While traditionally underutilized in peripheral neuropathy, imaging techniques like ultrasound and MRI are gaining recognition for their role in visualizing nerve abnormalities and guiding biopsy procedures.
Evaluating peripheral neuropathy requires a meticulous approach, considering its diverse etiologies and manifestations. A thorough history and physical examination, guided laboratory investigations, and the judicious use of imaging techniques form the cornerstone of this evaluation. As our understanding of peripheral neuropathy evolves, so too must our approach to its evaluation, ensuring that patients receive timely and appropriate management.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation